ARC-9: A randomized study to evaluate etrumadenant based treatment combinations in previously treated metastatic colorectal cancer (mCRC). May 29, 2024 sarah JonasResearch Alert Post Views: 78 For this presentation at ASCO 2024, please email the media contact for more information.